Rangers Face Tough Questions After Chermiti's ACL Injury
Youssef Chermiti’s ACL injury has stopped Rangers in their tracks – and the reaction from supporters says as much about the club’s long-term planning as it does about one desperately unlucky striker.
The immediate sympathy is obvious. One fan, Ian, called it “a terrible injury” and said there was “no point complaining about it,” only that he was gutted for the player. Another, Sally, stressed his age and recovery prospects, but didn’t sugar-coat the wider impact: an ACL “will heal,” she said, but warned he is “unlikely” to be the same player and predicted a dramatic drop in his transfer value. For a club that leans heavily on trading players at the right time, that hits a nerve.
Because this isn’t just about a knee. It’s about a pattern.
Graeme cut straight to the core of the frustration. He wants Chermiti to recover, of course, but sees the situation as “classic Rangers,” pointing to Alfredo Morelos, Ryan Kent and Nicolas Raskin as examples of assets not moved on at peak value. In his eyes, “poor strategy is literally costing the club money” all over again. Chermiti’s setback, to him, is not an isolated stroke of bad luck – it’s another chapter in a recurring story.
The timing only deepens the anxiety. European qualifiers already looked like a slog; now they’ll be tackled without the club’s key forward option. Another Ian spelled it out: Ryan Naderi and Bojan Miovski “have to step up,” and the injury “could not have happened at a worse time.” The margin for error in Europe was slim. It just got slimmer.
So where do Rangers turn? The consensus from the stands is clear: they need another striker, and they need one quickly. But that demand collides head‑on with a second, louder concern – the money.
Iain voiced what plenty are whispering. He fears Rangers are “spending ourselves into a black hole,” pointing to “£6m signings here, there and everywhere.” His questions are blunt and uncomfortable: have the board already spent Europa League money before earning it? Have they gambled on big future fees for Chermiti and Raskin that may now never materialise? “Where is this money coming from?” he asks. The injury hasn’t just weakened the squad; it has shone a harsh light on the balance sheet.
Not everyone is willing to chalk this up to misfortune. James took a harsher line, insisting Chermiti should have been left out of the team and “definitely should have sold him for £22m.” That figure hangs in the air like a regret. Whether or not that fee was ever truly on the table, it has become a symbol for supporters who feel Rangers repeatedly hesitate at the wrong moment and pay for it later.
What unites all these voices is a sense that the club stands at a crossroads. Chermiti will now begin the long, lonely road back from an ACL tear. Rangers, at the same time, must navigate a transfer window, a European campaign and a fragile financial landscape without the striker they were banking on – both on the pitch and, many believe, on the balance sheet.
The player’s recovery will take months. The board’s next decisions will define far longer than that.
